Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stuart Montgomery

Showing results (81-90 of 113) with videos related to

Pageof 12
Sort By:
European Archives of Psychiatry and Clinical Neuroscience|January 6, 2022
The sociodemographic and clinical profile of patients with major depressive disorder receiving SSRIs as first-line antidepressant treatment in European countriesGernot Fugger, Lucie Bartova, Chiara Fabbri, et al.
European Archives of Psychiatry and Clinical Neuroscience|October 20, 2012
The impact of Cytochrome P450 CYP1A2, CYP2C9, CYP2C19 and CYP2D6 genes on suicide attempt and suicide risk-a European multicentre study on treatment-resistant major depressive disorderPeter Höfer, Alexandra Schosser, Raffaella Calati, et al.
American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics|February 22, 2022
Polygenic risk scores for neuropsychiatric, inflammatory, and cardio-metabolic traits highlight possible genetic overlap with suicide attempt and treatment-emergent suicidal ideationGiuseppe Fanelli, Marcus Sokolowski, Danuta Wasserman, et al.
International Clinical Psychopharmacology|December 29, 2010
Brain-derived neurotrophic factor gene polymorphisms: influence on treatment response phenotypes of major depressive disorderNeslihan Aygun Kocabas, Irina Antonijevic, Carole Faghel, et al.
The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry|September 9, 2010
Dysbindin gene (DTNBP1) in major depressive disorder (MDD) patients: lack of association with clinical phenotypesNeslihan Aygun Kocabas, Irina Antonijevic, Carole Faghel, et al.
Current Medicinal Chemistry|January 5, 2021
Research Domain Criteria (RDoC): A Perspective to Probe the Biological Background behind Treatment Efficacy in DepressionMarco Calabrò, Chiara Fabbri, Siegfried Kasper, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|August 2, 2020
Drug repositioning for treatment-resistant depression: Hypotheses from a pharmacogenomic studyChiara Fabbri, Siegfried Kasper, Joseph Zohar, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|October 10, 2017
Pleiotropic genes in psychiatry: Calcium channels and the stress-related FKBP5 gene in antidepressant resistanceChiara Fabbri, Filippo Corponi, Diego Albani, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|July 12, 2025
Clinical predictors of treatment resistant depressionAlessandro Serretti, Siegfried Kasper, Lucie Bartova, et al.
Journal of Affective Disorders|October 24, 2024
Hypomanic symptoms in major depressive disorder: Prognostic impact and treatment issuesPaolo Olgiati, Siegfried Kasper, Joseph Zohar, et al.
Pageof 12

Showing results (81-90 of 113) with videos related to

Sort By:
Pageof 12
European Archives of Psychiatry and Clinical Neuroscience|January 6, 2022
The sociodemographic and clinical profile of patients with major depressive disorder receiving SSRIs as first-line antidepressant treatment in European countriesGernot Fugger, Lucie Bartova, Chiara Fabbri, et al.
European Archives of Psychiatry and Clinical Neuroscience|October 20, 2012
The impact of Cytochrome P450 CYP1A2, CYP2C9, CYP2C19 and CYP2D6 genes on suicide attempt and suicide risk-a European multicentre study on treatment-resistant major depressive disorderPeter Höfer, Alexandra Schosser, Raffaella Calati, et al.
American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics|February 22, 2022
Polygenic risk scores for neuropsychiatric, inflammatory, and cardio-metabolic traits highlight possible genetic overlap with suicide attempt and treatment-emergent suicidal ideationGiuseppe Fanelli, Marcus Sokolowski, Danuta Wasserman, et al.
International Clinical Psychopharmacology|December 29, 2010
Brain-derived neurotrophic factor gene polymorphisms: influence on treatment response phenotypes of major depressive disorderNeslihan Aygun Kocabas, Irina Antonijevic, Carole Faghel, et al.
The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry|September 9, 2010
Dysbindin gene (DTNBP1) in major depressive disorder (MDD) patients: lack of association with clinical phenotypesNeslihan Aygun Kocabas, Irina Antonijevic, Carole Faghel, et al.
Current Medicinal Chemistry|January 5, 2021
Research Domain Criteria (RDoC): A Perspective to Probe the Biological Background behind Treatment Efficacy in DepressionMarco Calabrò, Chiara Fabbri, Siegfried Kasper, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|August 2, 2020
Drug repositioning for treatment-resistant depression: Hypotheses from a pharmacogenomic studyChiara Fabbri, Siegfried Kasper, Joseph Zohar, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|October 10, 2017
Pleiotropic genes in psychiatry: Calcium channels and the stress-related FKBP5 gene in antidepressant resistanceChiara Fabbri, Filippo Corponi, Diego Albani, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|July 12, 2025
Clinical predictors of treatment resistant depressionAlessandro Serretti, Siegfried Kasper, Lucie Bartova, et al.
Journal of Affective Disorders|October 24, 2024
Hypomanic symptoms in major depressive disorder: Prognostic impact and treatment issuesPaolo Olgiati, Siegfried Kasper, Joseph Zohar, et al.
Pageof 12